Safety pharmacology 2023 and implementation of the ICH E14/S7B Q&A guidance document-Reference-Cited by-同舟云学术

Safety pharmacology 2023 and implementation of the ICH E14/S7B Q&A guidance document

Published:2023-09 Issue: Volume:123 Page:107300
ISSN:1056-8719
Container-title:Journal of Pharmacological and Toxicological Methods
language:en
Short-container-title:Journal of Pharmacological and Toxicological Methods

Author:

Pugsley Michael K.,Koshman Yevgeniya E.,Foley C. Michael,Winters Brett R.,Authier Simon,Curtis Michael J.

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference44 articles.

1. S7A safety pharmacology studies for human pharmaceuticals. International Council for Harmonisation of technical requirements for pharmaceuticals for human use;Anonymous;Federal Register,2001

2. ICH S7B: The non-clinical evaluation of the potential fro delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. International Council for Harmonisation of technical requirements for Pharmaceuticals for Human use;Anonymous;Federal Register,2005

3. ICH E14: The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Internal Council for Harmonisation of technical requirements for Pharmaceuticals for Human use;Anonymous;Federal Register,2005

4. International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment;Blinova;Cell Reports,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative approaches to cardiovascular safety pharmacology assessment;Journal of Pharmacological and Toxicological Methods;2024-07

2. Liver Systems in Safety Pharmacology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

3. Status of Safety Pharmacology and Present Guidelines;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

4. Innovative Approaches to Cardiovascular Safety Pharmacology Assessment;2024